{"database": "openregs", "table": "dockets", "rows": [["FDA-2006-D-0032", "FDA", "Guidance for Clinical Investigators, Institutional Review Boards and Sponsors Process for Handling Referrals to FDA Under 21 CFR 50.54 : Additional Safeguards for Children in Clinical Investigations", "Nonrulemaking", "2021-09-01T01:01:19Z", "0b000064804420c2"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2006-D-0032"], "units": {}, "query_ms": 39.678960922174156, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}